Your browser doesn't support javascript.
loading
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
Malingré, M M; Schellens, J H; Van Tellingen, O; Ouwehand, M; Bardelmeijer, H A; Rosing, H; Koopman, F J; Schot, M E; Ten Bokkel Huinink, W W; Beijnen, J H.
Affiliation
  • Malingré MM; Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Br J Cancer ; 85(10): 1472-7, 2001 Nov 16.
Article in En | MEDLINE | ID: mdl-11720431
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Glycerol / Intestinal Absorption / Neoplasms / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2001 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paclitaxel / Glycerol / Intestinal Absorption / Neoplasms / Antineoplastic Agents, Phytogenic Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2001 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido